Big biotech, Big pharma, Partnering, Pharma

Amgen biopharma partners with Roche for neutropenia drugs

Posted on 23 October 2013

Tags: , , ,

Amgen biopharma partners by acquiring Roche's rights to the neutropenia drugs filgrastim and pegfilgrastim, effective January 1, 2014.

An undisclosed price.

Filgrastim and pegfilgrastim are marketed by Amgen in the United States and Europe under the trade names Neupogen® and Neulasta®, respectively.

Roche has held the rights to filgrastim and pegfilgrastim under license from Kirin-Amgen, in Eastern Europe, Latin America, Asia, the Middle East, and Africa.

Amgen said it will begin distributing and selling product “as soon as practical” in countries where the company has an existing commercial presence.

The biopharma partners expects the deal will be accretive to its earnings starting in 2014.

Japan’s Kyowa Hakko Kirin will continue to retain product rights and to market filgrastim and pegfilgrastim in parts of Asia, including China and Japan.


Report: Central Nervous System Partnering Terms and Agreements

Report: Partnering Deals and Alliances with Amgen

Report: Partnering Deals and Alliances with Roche

Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply